Skip to main content
Goodwill Pharma Plc logo

Goodwill Pharma Plc — Investor Relations & Filings

Ticker · GWPH ISIN · HU0000199575 BUD Manufacturing
Open in API
Filings indexed 35 across all filing types
Latest filing 2026-03-31 Regulatory Filings
Country HU Hungary
Listing BUD GWPH

About Goodwill Pharma Plc

www.goodwillpharma.com

Goodwill Pharma Plc is a fully integrated pharmaceutical service provider engaged in the development, manufacturing, and distribution of therapeutic products. Its portfolio comprises medicines, food supplements, and medical devices. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive solutions that span the entire pharmaceutical lifecycle, from research and development to large-scale commercial manufacturing. Core services include product development, regulatory affairs, pharmacovigilance, production, logistics, and marketing support. Goodwill Pharma collaborates with academic institutions on research projects to foster innovation. The company primarily serves markets in Central and Eastern Europe, with an expanding international presence through various partnerships.

Recent filings

Filing Released Lang Actions
Tájékoztatás alaptőkéről és szavazati jogokról
Regulatory Filings Classification · 1% confidence The document is a statutory disclosure by Goodwill Pharma Nyrt providing the amount of share capital and number of voting rights as of March 31, 2026, under the Hungarian Capital Market Act. It does not announce a meeting result, dividend, management change, or financial results, nor is it a full financial report. It is a regulatory disclosure that does not fit other specific categories and thus falls under the general regulatory filings category.
2026-03-31 Hungarian
Közgyűlési meghívó
AGM Information Classification · 1% confidence The document is a formal “Meghívó” (invitation) to the annual general meeting of Goodwill Pharma Nyrt. on April 29, 2026, detailing the meeting agenda, voting rights, proxy procedures, and logistical information. It is clearly a notice related to the AGM itself, not the Annual Report or a presentation, nor an earnings release or proxy statement in the US sense. Therefore it falls under AGM Information.
2026-03-27 Hungarian
Rendkívüli tájékoztatás
M&A Activity Classification · 1% confidence The document is an official announcement from Goodwill Pharma Nyrt. regarding a non-binding offer for an acquisition of a Polish pharmaceutical company and the subsequent commencement of the due diligence phase. This falls under the category of M&A activity (mergers and acquisitions).
2026-03-13 Hungarian
Rendkívüli tájékoztatás
Regulatory Filings Classification · 1% confidence The document is a short announcement (approx. 1100 characters) from Goodwill Pharma Nyrt. regarding the receipt of an updated GMP manufacturing license from the National Public Health and Pharmaceutical Center (NNGYK). It does not contain full financial statements, audit reports, or proxy materials. As it is a regulatory announcement regarding company operations and licensing that does not fit into specific categories like M&A or dividends, it falls under the general regulatory filing category.
2026-03-02 Hungarian
Tájékoztatás alaptőkéről és szavazati jogokról
Share Issue/Capital Change Classification · 1% confidence The document is a formal notification from Goodwill Pharma Nyrt. regarding the number of shares and voting rights as of February 28, 2026. This type of disclosure is a standard regulatory requirement in many jurisdictions (often referred to as a 'voting rights announcement' or 'share capital disclosure'). Since it does not fit into specific categories like 'Major Shareholding Notification' (which tracks changes in ownership by third parties) or 'Share Issue' (which announces new capital raises), it falls under the general regulatory filing category for corporate disclosures.
2026-03-02 Hungarian
Rendkívüli tájékoztatás
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 1,300 characters) from Goodwill Pharma Nyrt. regarding the approval of a project contract modification by a regulatory authority (Irányító Hatóság). It does not contain financial statements, annual reports, or specific shareholder meeting materials. As it is a general regulatory update regarding company operations and project status that does not fit into more specific categories like M&A or dividends, it is classified as a general regulatory filing.
2026-02-24 Hungarian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.